CVE-2013-2465
Oracle Java SE Unspecified Vulnerability
- Actively exploited
- Used by ransomware
- Critical · 9.8 of 10
- Exploited since
- 28 Mar 2022 added to the CISA list
- Chance of attacks
- 99% in the next 30 days (FIRST EPSS)
- Fix deadline
- 18 Apr 2022 for US federal agencies
- Published
- 19 Jun 2013 in the NVD
What this means
Unspecified vulnerability in the Java Runtime Environment (JRE) component in Oracle Java SE allows remote attackers to affect confidentiality, integrity, and availability via Unknown vectors related to 2D
CISA
Unspecified vulnerability in the Java Runtime Environment (JRE) component in Oracle Java SE 7 Update 21 and earlier, 6 Update 45 and earlier, and 5.0 Update 45 and earlier, and OpenJDK 7, allows remote attackers to affect confidentiality, integrity, and availability via unknown vectors related to 2D. NOTE: the previous information is from the June 2013 CPU. Oracle has not commented on claims from another vendor that this issue allows remote attackers to bypass the Java sandbox via vectors related to "Incorrect image channel verification" in 2D.
NIST National Vulnerability Database
What to do
Apply updates per vendor instructions.
CISA's required action. If you use the product, install the vendor's update as soon as possible.
Affected
- n/a n/a
Official sources
- nvd.nist.gov/vuln/detail/CVE-2013-2465
- advisories.mageia.org/MGASA-2013-0185.html
- h20000.www2.hp.com/bizsupport/TechSupport/Document.jsp?objectID=c03898880
- hg.openjdk.java.net/jdk7u/jdk7u-dev/jdk/rev/2a9c79db0040
- lists.opensuse.org/opensuse-security-announce/2013-07/msg00026.html
- lists.opensuse.org/opensuse-security-announce/2013-07/msg00027.html
- lists.opensuse.org/opensuse-security-announce/2013-07/msg00028.html
- lists.opensuse.org/opensuse-security-announce/2013-07/msg00029.html
- lists.opensuse.org/opensuse-security-announce/2013-07/msg00031.html
Data from the NIST National Vulnerability Database, the CISA Known Exploited Vulnerabilities list, FIRST EPSS and ENISA, checked 18 Nov 2026. CVSS vector CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.